Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment

The basal forebrain area (BFA) is closely connected to the hippocampus by virtue of cholinergic neuronal projections. Structural neuroimaging studies have shown reduced volumes of both structures in Alzheimer's disease and its prodromal stage mild cognitive impairment (MCI), but generally not in the same investigation. By combining voxel based morphometry and region of interest methods, we measured the grey matter (GM) volumes of the two brain regions with the goal of elucidating their contributions to MCI and its two subtypes (amnestic MCI and non-amnestic MCI) in an elderly epidemiological sample. The results replicated previous findings that the atrophies of both brain regions were associated with an increased likelihood of MCI and its two subtypes. However, in a regression model for the prediction of MCI with GM volumes for both regions used as predictors, only hippocampal atrophy remained significant. Two possible interpretations for this pattern of results were discussed. One is that the observed correlation between BFA atrophy and MCI is spurious and due to the hippocampal atrophy correlated with both. Alternatively, our observation is consistent with the possibility that BFA atrophy has a causal effect on MCI, which is mediated via its influence on hippocampal atrophy. Furthermore, we found that the left hippocampal atrophy had a stronger effect than the right hippocampus and bilateral BFA in the prediction of amnestic MCI occurrence when the four unilateral areas were entered into one regression model. In addition, a slight but statistically significant difference was found in the left hippocampal volume between APOE ε4 allele carriers and non-carriers, consistent with prior studies.

[1]  Xin Yu,et al.  Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. , 2003, The American journal of psychiatry.

[2]  E. Perry The cholinergic system in old age and Alzheimer's disease. , 1980, Age and ageing.

[3]  C. Bottino,et al.  Volumetric MRI Measurements Can Differentiate Alzheimer's Disease, Mild Cognitive Impairment, and Normal Aging , 2002, International Psychogeriatrics.

[4]  Oscar L. Lopez,et al.  Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease , 2008, Alzheimer's & Dementia.

[5]  Katrin Amunts,et al.  Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain , 2008, NeuroImage.

[6]  Henry Brodaty,et al.  Effect of different impairment criteria on prevalence of “objective” mild cognitive impairment in a community sample. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[7]  H. Hanyu,et al.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. , 2002, AJNR. American journal of neuroradiology.

[8]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[9]  D. Price,et al.  Topography of the Magnocellular Basal Forebrain System in Human Brain , 1984, Journal of neuropathology and experimental neurology.

[10]  C. Jack,et al.  Mild cognitive impairment: ten years later. , 2009, Archives of neurology.

[11]  Sterling C. Johnson,et al.  Magnetic Resonance Imaging Characterization of Brain Structure and Function in Mild Cognitive Impairment: A Review , 2008, Journal of the American Geriatrics Society.

[12]  Kiralee M. Hayashi,et al.  Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. , 2006, Archives of neurology.

[13]  L. Wilkinson,et al.  Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system , 1994, Neuroscience.

[14]  F. Schmitt,et al.  Brain structural alterations before mild cognitive impairment , 2007, Neurology.

[15]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[16]  P. Sachdev,et al.  The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70–90 years , 2010, International Psychogeriatrics.

[17]  Jennifer L. Whitwell,et al.  Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. , 2008, Archives of neurology.

[18]  J. Pantel,et al.  Mild Cognitive Impairment in the Elderly is Associated with Volume Loss of the Cholinergic Basal Forebrain Region , 2010, Biological Psychiatry.

[19]  H. Soininen,et al.  Apolipoprotein E ε4 Allele Is Associated with Increased Atrophy in Progressive Mild Cognitive Impairment: A Voxel-Based Morphometric Study , 2008, Neurodegenerative Diseases.

[20]  Hiroaki Kazui,et al.  Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? , 2005, The American journal of psychiatry.

[21]  H. Soininen,et al.  Hippocampus and entorhinal cortex in mild cognitive impairment and early AD , 2004, Neurobiology of Aging.

[22]  R. Nicoll,et al.  Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells. , 1983, Science.

[23]  H. Kraemer,et al.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.

[24]  J. Brewer,et al.  High-throughput, Fully Automated Volumetry for Prediction of MMSE and CDR Decline in Mild Cognitive Impairment , 2009, Alzheimer disease and associated disorders.

[25]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[26]  C. Jack,et al.  Patterns of atrophy differ among specific subtypes of mild cognitive impairment. , 2007, Archives of neurology.

[27]  K. Amunts,et al.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. , 2010, Cerebral cortex.

[28]  Anders M. Dale,et al.  Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.

[29]  S. Resnick,et al.  Longitudinal pattern of regional brain volume change differentiates normal aging from MCI , 2009, Neurology.

[30]  H. Möller,et al.  Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. , 2005, Brain : a journal of neurology.

[31]  Peter Stoeter,et al.  Functional implications of hippocampal volume and diffusivity in mild cognitive impairment , 2005, NeuroImage.

[32]  R. O’Brien,et al.  A Caution Regarding Rules of Thumb for Variance Inflation Factors , 2007 .

[33]  C. Davies,et al.  Cholinergic modulation of hippocampal cells and circuits , 2005, The Journal of physiology.

[34]  H C Charles,et al.  Impact of APOE in mild cognitive impairment , 2004, Neurology.

[35]  J. Berger-Sweeney The effects of neonatal basal forebrain lesions oncognition : towards understanding the developmental roleof the cholinergic basal forebrain , 1998, International Journal of Developmental Neuroscience.

[36]  D. Bennett,et al.  Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[38]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[39]  R. Verwer,et al.  ApoE ϵ4 Genotype Is Accompanied by Lower Metabolic Activity in Nucleus Basalis of Meynert Neurons in Alzheimer Patients and Controls as Indicated by the Size of the Golgi Apparatus , 2004, Journal of neuropathology and experimental neurology.

[40]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[41]  C. Geula,et al.  Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase , 1988, The Journal of comparative neurology.